期刊文献+

警惕硫唑嘌呤引起的急性骨髓抑制 被引量:2

下载PDF
导出
作者 纪立伟 刘岳
机构地区 卫生部北京医院
出处 《中国临床医生杂志》 2009年第9期64-65,共2页 Chinese Journal For Clinicians
  • 相关文献

参考文献4

二级参考文献25

  • 1詹钟平,杨岫岩,黄民,王一西,连帆,梁柳琴,叶玉津,许韩师.硫唑嘌呤致血液系统危象的临床特征与酶学基础[J].中华风湿病学杂志,2005,9(3):145-148. 被引量:16
  • 2赵峻,张莉蓉,乔海灵.免疫抑制剂硫唑嘌呤的药物不良反应[J].中国误诊学杂志,2006,6(5):839-841. 被引量:25
  • 3Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. New Engl J Med, 2003, 349: 36-44.
  • 4Contreras G, Pardo V, Leclercq B, et al. Sequential therapies for proliferative lupus nephritis. New Engl J Med, 2004, 350: 971-980.
  • 5Weinshilboum R . Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos, 2001, 29: 601-605.
  • 6Krynetski EY, Evans WE. Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.Pharmacology, 2000, 61: 136-146.
  • 7Stolk JN, Boerbooms AMT, Abreu RAD, et al. Reduced thiopurine methyltransferase activity and development of side effects of azathioprine treatment in patients with rheumatoid arthritis.Arthritis Rheum, 1998, 41: 1858-1866.
  • 8McLeod HL Siva C. The thiopurine S-methyltransferase gene locus-implications for clinical pharmacogenomics. Pharmacogenomics, 2002, 3: 89-98.
  • 9Jang IJ, Shin SG, Lee KH, et al. Erythrocyte thiopurine methyltransferase activity in a Korean population. Br J Clin Pharmacol,1996, 42: 638-641.
  • 10Lee EJ, Kalow W. Thiopurine S-methyltransferase activity in a Chinese population. Clin Pharmacol Ther, 1993, 54: 28-33.

共引文献22

同被引文献14

  • 1赵峻,张莉蓉,乔海灵.免疫抑制剂硫唑嘌呤的药物不良反应[J].中国误诊学杂志,2006,6(5):839-841. 被引量:25
  • 2于连英,傅淑霞.硫唑嘌呤致严重脱发1例[J].临床荟萃,2007,22(3):228-228. 被引量:5
  • 3白瑛 方玉复 魏玉平.硫唑嘌呤致急性粒细胞缺乏症死亡1例.中国皮肤性病学杂志,1998,12(2):107-107.
  • 4Sheu SJ. Update on uveomeningoeneephalitides [ J ]. Curr Opin Neu- ro1,2005,18 ( 3 ) :323-329.
  • 5Smith JR, Rosenbaum JT. Neurological concomitants of uveitis [ J ]. Br J Ophthalmol,2004, 88(12) :1498-1499.
  • 6Iwata NK, Hayashi T, Numaga J, et al. Fits and deafness [ J ]. Lancet Neuro1,2002,1 (6) :387-388.
  • 7Lubin JR, Loewenstein JI, Frederick AR. Vogt-Koyanagi-Harada syn- drome with focal neurologic signs [ J ]. Am J Ophthalmol, 1981 , 91 (3) :332-341.
  • 8Dahbour SS. MRI documented acute myelitis in a patient with Vogt- Koyanagi-Harada syndrome : first report [ J 1- Clin Neurol Neurosurg, 2009,111 (2) :200-202.
  • 9Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease : report of an international committee on nomenclature [ J ]. Am J Ophthalmol,2001,131 ( 5 ) :647 -652.
  • 10Jarius S,Aboul-Enein F,Waters P,et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica [ J]. Brain, 2008,131 (Ptll ) :3072-3080.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部